PL1898909T3 - Pochodne chinoliny jako środki przeciwbakteryjne - Google Patents
Pochodne chinoliny jako środki przeciwbakteryjneInfo
- Publication number
- PL1898909T3 PL1898909T3 PL06763888T PL06763888T PL1898909T3 PL 1898909 T3 PL1898909 T3 PL 1898909T3 PL 06763888 T PL06763888 T PL 06763888T PL 06763888 T PL06763888 T PL 06763888T PL 1898909 T3 PL1898909 T3 PL 1898909T3
- Authority
- PL
- Poland
- Prior art keywords
- antibacterial agents
- quinoline derivatives
- quinoline
- derivatives
- antibacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05105755 | 2005-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1898909T3 true PL1898909T3 (pl) | 2017-03-31 |
Family
ID=35447198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06763888T PL1898909T3 (pl) | 2005-06-28 | 2006-06-26 | Pochodne chinoliny jako środki przeciwbakteryjne |
Country Status (32)
Country | Link |
---|---|
US (1) | US20130030016A1 (pl) |
EP (1) | EP1898909B1 (pl) |
JP (1) | JP5193857B2 (pl) |
KR (1) | KR101329587B1 (pl) |
CN (1) | CN101252927B (pl) |
AP (1) | AP2547A (pl) |
AR (1) | AR054804A1 (pl) |
AU (1) | AU2006263882B2 (pl) |
BR (1) | BRPI0613999B8 (pl) |
CA (1) | CA2612614C (pl) |
CY (1) | CY1119402T1 (pl) |
DK (1) | DK1898909T3 (pl) |
EA (1) | EA014431B1 (pl) |
ES (1) | ES2610472T3 (pl) |
HK (1) | HK1120732A1 (pl) |
HR (1) | HRP20170044T1 (pl) |
HU (1) | HUE030264T2 (pl) |
IL (1) | IL188395A (pl) |
JO (1) | JO3322B1 (pl) |
LT (1) | LT1898909T (pl) |
MX (1) | MX2008000079A (pl) |
MY (1) | MY173664A (pl) |
NO (1) | NO341285B1 (pl) |
NZ (1) | NZ564340A (pl) |
PL (1) | PL1898909T3 (pl) |
PT (1) | PT1898909T (pl) |
RS (1) | RS55601B1 (pl) |
SG (1) | SG166798A1 (pl) |
TW (1) | TWI413520B (pl) |
UA (1) | UA88701C2 (pl) |
WO (1) | WO2007000434A1 (pl) |
ZA (1) | ZA200711148B (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2752B1 (en) | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JP5397881B2 (ja) * | 2008-09-04 | 2014-01-22 | 昇一 城武 | グラム陽性細菌用抗菌剤及び抗菌活性増強剤 |
US9617244B2 (en) | 2012-04-27 | 2017-04-11 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
EP2841425B1 (en) | 2012-04-27 | 2016-03-23 | Janssen Pharmaceutica, N.V. | Antibacterial quinoline derivatives |
AU2018348796A1 (en) * | 2017-10-13 | 2020-05-07 | Griffith University | Zinc ionophores and uses thereof |
CN110606825A (zh) * | 2019-10-30 | 2019-12-24 | 成都海杰亚医药科技有限公司 | 一种制备吡啶-2-硫醇的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
PL222801B1 (pl) * | 2002-07-25 | 2016-09-30 | Janssen Pharmaceutica Nv | Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je |
EP1753427B1 (en) * | 2004-05-28 | 2008-04-02 | Janssen Pharmaceutica N.V. | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
EE05697B1 (et) * | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
-
2006
- 2006-06-26 PT PT67638882T patent/PT1898909T/pt unknown
- 2006-06-26 MY MYPI20063021A patent/MY173664A/en unknown
- 2006-06-26 MX MX2008000079A patent/MX2008000079A/es active IP Right Grant
- 2006-06-26 DK DK06763888.2T patent/DK1898909T3/en active
- 2006-06-26 AP AP2008004298A patent/AP2547A/xx active
- 2006-06-26 SG SG201007976-2A patent/SG166798A1/en unknown
- 2006-06-26 EA EA200800151A patent/EA014431B1/ru unknown
- 2006-06-26 JP JP2008518809A patent/JP5193857B2/ja active Active
- 2006-06-26 UA UAA200714928A patent/UA88701C2/ru unknown
- 2006-06-26 CA CA2612614A patent/CA2612614C/en active Active
- 2006-06-26 NZ NZ564340A patent/NZ564340A/en unknown
- 2006-06-26 KR KR1020087002246A patent/KR101329587B1/ko active IP Right Grant
- 2006-06-26 BR BRPI0613999A patent/BRPI0613999B8/pt not_active IP Right Cessation
- 2006-06-26 HU HUE06763888A patent/HUE030264T2/en unknown
- 2006-06-26 LT LTEP06763888.2T patent/LT1898909T/lt unknown
- 2006-06-26 PL PL06763888T patent/PL1898909T3/pl unknown
- 2006-06-26 AU AU2006263882A patent/AU2006263882B2/en active Active
- 2006-06-26 WO PCT/EP2006/063552 patent/WO2007000434A1/en active Application Filing
- 2006-06-26 ES ES06763888.2T patent/ES2610472T3/es active Active
- 2006-06-26 EP EP06763888.2A patent/EP1898909B1/en active Active
- 2006-06-26 CN CN200680031302.9A patent/CN101252927B/zh active Active
- 2006-06-26 RS RS20170045A patent/RS55601B1/sr unknown
- 2006-06-27 TW TW095123049A patent/TWI413520B/zh active
- 2006-06-27 AR ARP060102758A patent/AR054804A1/es unknown
- 2006-06-29 JO JOP/2006/0183A patent/JO3322B1/ar active
-
2007
- 2007-12-20 ZA ZA2007/11148A patent/ZA200711148B/en unknown
- 2007-12-25 IL IL188395A patent/IL188395A/en active IP Right Grant
-
2008
- 2008-01-28 NO NO20080499A patent/NO341285B1/no not_active IP Right Cessation
- 2008-11-17 HK HK08112566.1A patent/HK1120732A1/xx unknown
-
2012
- 2012-08-07 US US13/568,569 patent/US20130030016A1/en not_active Abandoned
-
2017
- 2017-01-11 HR HRP20170044TT patent/HRP20170044T1/hr unknown
- 2017-01-18 CY CY20171100071T patent/CY1119402T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2654A (en) | Quinoline derivatives as antibacterial agents | |
ZA200801108B (en) | Quinoline derivatives as antibacterial agents | |
SG165348A1 (en) | Quinoline derivatives as antibacterial agents | |
HK1120732A1 (en) | Quinoline derivatives as antibacterial agents | |
HK1124232A1 (en) | Quinoline derivatives as antibacterial agents | |
HK1122730A1 (en) | Quinoline derivatives as antibacterial agents | |
HK1120734A1 (en) | Quinoline derivatives as antibacterial agents | |
ZA200710698B (en) | Quinoline derivatives as antibacterial agents |